-
DEVELOPING A PATIENT-REPORTED OUTCOME (PRO) MEASURE FOR JAPANESE PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC)
Mar 18, 2026, 21:38 PM -
HYPERTENSION CONTROL IN TREATED U.S. CANCER SURVIVORS UNDER THE 2017 ACC/AHA GUIDELINE: AN ANALYSIS OF NHANES 2011-2023
Mar 18, 2026, 21:38 PM -
IMPACT OF TAFAMIDIS USE IN COLOMBIAN PATIENTS DIAGNOSED WITH ATTR-CM ON HEALTH-RELATED QUALITY OF LIFE DURING TWO YEARS OF FOLLOW-UP: REAL WORLD STUDY IN COLOMBIA
Mar 18, 2026, 21:38 PM -
AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES
Mar 18, 2026, 21:38 PM -
INCIDENCE OF IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED PNEUMONITIS AMONG NON-SMALL CELL LUNG CANCER PATIENTS WITH AND WITHOUT PRE-EXISTING COPD
Mar 18, 2026, 21:38 PM -
EFFICACY OF PANITUMUMAB VS. CETUXIMAB PLUS CHEMOTHERAPY IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK: AN ANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON
Mar 18, 2026, 21:38 PM -
PATIENT PREFERENCES FOR TREATMENT SELECTION IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
USE OF REAL-WORLD EVIDENCE IN PRE-APPROVAL ASSESSMENTS FOR RARE AND ULTRA-RARE DISEASE THERAPIES IN UK, GERMANY, FRANCE, AND THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SELF-REPORTED MARIJUANA USE, PAIN LEVELS, AND OPIOID USE AMONG ADULT CANCER SURVIVORS IN ARKANSAS
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARATIVE EFFECTIVENESS OF LUTETIUM-177-PSMA-617 VERSUS CABAZITAXEL FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Mar 18, 2026, 21:38 PM -
TRANSFORMING VACCINE AVAILABILITY THROUGH REAL-TIME LAST-MILE VISIBILITY: A SYSTEMS APPROACH TO STRENGTHENING STOCK DATA IN NIGERIAN PHC FACILITIES
Mar 18, 2026, 21:38 PM -
EXAMINING THE ASSOCIATION BETWEEN PROBLEMATIC INTERNET USE AND MENTAL HEALTH AMONG ADOLESCENTS
Mar 18, 2026, 21:38 PM -
PREFERENCES FOR ADOPTING A MOBILE HEALTH APP: A BEST-WORST SCALING AND DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN MEN WITH PROSTATE CANCER TREATED WITH ANDROGEN DEPRIVATION THERAPY USING REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
REAL-WORLD DISEASE ACTIVITY AND TREATMENT RESPONSIVENESS AMONG ADULTS WITH RHEUMATOID ARTHRITIS
Mar 18, 2026, 21:38 PM -
DEFINING VALUE IN A SEVERE, MULTISYSTEM DISEASE: LESSONS FROM ECONOMIC MODELS OF SYSTEMIC LUPUS ERYTHEMATOSUS
Mar 18, 2026, 21:38 PM -
PEMBROLIZUMAB ALONE VERSUS CHEMO-IMMUNOTHERAPY IN METASTATIC NSCLC: A 2024 MEDICARE-BASED MARKOV COST-EFFECTIVENESS ANALYSIS
Mar 18, 2026, 21:38 PM -
CHOOSING FOR THE WORSE-OFF: A STRUCTURAL SOCIAL WELFARE MODEL OF EQUITY-EFFICIENCY PREFERENCES IN TYPE 2 DIABETES TREATMENT CHOICES
Mar 18, 2026, 21:38 PM -
INCIDENT INSOMNIA AND STRESS-RELATED MENTAL HEALTH OUTCOMES AFTER NUTRITIONAL SUPPLEMENT INITIATION IN ADULTS WITH TYPE 2 DIABETES: A MULTI-TIME-WINDOW COHORT STUDY USING THE TRINETX GLOBAL COLLABORATIVE NETWORK
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY, RISK FACTORS AND BURDEN ASSOCIATED WITH PERITONEAL METASTASES (PM) IN GASTRIC CANCER (GC): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM
